using a novel machine learning model to analyze and predict the outcomes of patients with ndmm
Published 1 year ago • 67 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
1:18
targeted therapies in r/r myeloma: novel approaches being explored
-
2:01
the key unmet needs in a post-allosct newly diagnosed myeloma setting
-
1:04
the future of mds management
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
2:04
state-of-the-art treatment for hr-mds
-
1:05
using whole genome sequencing to identify novel predictors for sct in patients with mds
-
1:00:49
design of microrna therapeutics
-
16:42
management of treatment-naïve lr-mds
-
1:03:21
nbe- journal club- landmark recent papers in breast cancer- dr. saumyta, dr. svs deo, dr. rosina
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
2:43
novel therapies in the future of mds treatment
-
1:15
novel therapies targeting the innate immune system in mds
-
1:26
the role of the bone marrow microenvironment in hematological malignancies
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
3:22
the role of micrornas in modulation of the immune escape of tumours
-
1:30
mosunetuzumab in the treatment of hcl: a case study
-
2:12
social media – a useful tool for hematological research
-
1:53
novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
-
17:56
the various effects of anesthetics via micrornas
-
2:55
chemotherapy-free approaches to al amyloidosis